Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
110.00
-2.00 (-1.79%)
At close: Aug 5, 2025

Recursion Pharmaceuticals Revenue

Recursion Pharmaceuticals had revenue of $19.22M USD in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.

Revenue (ttm)
$64.60M
Revenue Growth
+30.14%
P/S Ratio
35.25
Revenue / Employee
$80.75K
Employees
800
Market Cap
42.94B MXN

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202458.84M14.26M32.00%
Dec 31, 202344.58M4.73M11.88%
Dec 31, 202239.84M29.67M291.46%
Dec 31, 202110.18M6.22M156.89%
Dec 31, 20203.96M1.64M70.85%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition